Demographics and the number of follow-up HCM patients who developed new symptoms or required medication changes and their respective ESC-SCD risk categories
| A total of 47 follow-up HCM patients were identified over a 6-month period in 2018 | ||||
|---|---|---|---|---|
| Age | 61.4 ± 12.2 | |||
| Male Gender | 26 | |||
| ESC-SCD Risk Stratification | N | Developed New Symptoms | Required Medication Changes | Cardiac admissions in 2-years |
| Low | 38 | 8 (21%) | 11 (29%) | 2 (5%) |
| Moderate | 4 | 1 (25%) | 2 (50%) | 0 (0%) |
| High | 4 | 1 (25%) | 2 (50%) | 0 (0%) |